Drugs, Advertising, and Risks Associated with Direct to Consumer Ads

If you have watched a news program, sporting event, or network television show recently you have seen multiple ads for drugs or devices that will change your life.  Whether it is “Larry the cable guy” for the “purple” pill, a handsome athletic looking couple looking for the right moment assisted by a “blue” pill, an [...]

October 23rd, 2013|Drug and Medical Device Litigation|0 Comments

Are Too Many Doctors Simply Sales People for Big Pharma?

Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011.  According to a new data reported in the Financial Times, that figure only includes the 12 leading drug makers who actually [...]